Why Foghorn Therapeutics Is Rising In Pre-market?

Loxo Oncology at Lilly (LLY), and Foghorn Therapeutics Inc. (FHTX) have entered a strategic collaboration to create oncology medicines by applying Foghorn's Gene Traffic Control platform. Foghorn will receive upfront consideration of $300 million in cash for the collaboration agreement. Foghorn will also receive an equity investment by Lilly of $80 million in Foghorn common shares at a price of $20 per share.

The collaboration includes a co-development and co-commercialization agreement for Foghorn's selective BRM oncology program and an additional undisclosed oncology target. Foghorn is eligible to receive royalties on ex-U.S. sales starting in the low double-digit range and escalating into the twenties.

Also, the collaboration includes three additional discovery programs using Foghorn's Gene Traffic Control platform. Foghorn may receive up to a total of $1.3 billion in potential development and commercialization milestones.

Lilly noted that there will be no change to the company's 2021 non-GAAP earnings per share guidance as a result of the deal.

Foghorn Therapeutics is developing multiple product candidates in oncology with two currently being investigated in clinical studies.

Shares of Foghorn Therapeutics were up 33% in pre-market trade on Monday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Swiss luxury goods group Compagnie Financiere Richemont AG reported Friday significantly higher profit in fiscal 2022 with strong growth in demand. The company also lifted its dividend, and announced a special dividend. Meanwhile, the shares were losing around 12 percent in the morning trading in Switzerland. Coeurd-Alene, Idaho-based White Cane Smoked Salmon LLC is recalling Wild Alaskan Cooked and Smoked Salmon as it contains undeclared wheat and soy, known allergens, the U.S. Food and Drug Administration said. The affected Alaskan Cooked and Smoked Salmon is packaged in vacuum bag, sold frozen, and there is no lot code or best by date on a package. Auto giant Ford Motor Co. (F) has issued a recall of about 39,000 2021 Expedition and Lincoln Navigator vehicles due to fire risk. The company has asked the customers of the recalled 2021 Ford Expedition and Lincoln Navigator SUVs to park their vehicles outside and away from structures while it investigates...
Follow RTT